1WHITEHEAD W E, PALSSON O, JONES K R.Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications [J]. Gastroenterology, 2002, 122:1140.
3MIWA J, ECHIZEN H, MATSUEDA K, et al. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrheapredominant patients and subjects with normal bowel habits [J]. Digestion, 2001,63:188.
4CROWELL M D, SHETZLINE M A, MOSES P L, et al. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function[J]. Curr Opin Investig Drugs , 2004 , 5: 55.
5STEENSJ,VANDER SCHAAR P J,PENNING C, et al. Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome[J].Neurogastroenterol Motil, 2002,14: 241.
6KOZLOWSKI C M, GREEN A, GRUNDY D, et al.The 5-HT3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat[J].Gut, 2000,46: 474.
7SCHIKOWSKI A, THEWISSEN M, MATHIS C, et al. Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum[J]. Neurogastroenterol Motil, 2002,14: 221.
8PATA C, ERDAL M E, DERICI E, et al. Serotonin transporter gene olymorphism in irritable bowel syndrome[J]. Am J Gastroenterol, 2002,97:1780.
9MOSES P L, BANNON C, LINDEN D R, et al. Evidence for altered serotonin signalling in IBD and constipation predominant IBS[J]. Am J Gastroenterol,2002,97: S274.
10CAMILLERI M, ATANASOVA E, CARLSON P J,et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome[J]. Gastroenterology, 2002,123: 425.
